David Greenwald
Directeur/Membre du Conseil chez Jaguar Gene Therapy LLC
Profil
David Greenwald is the founder of Relay Technology Management, Inc. which was founded in 2007.
He was the Chief Executive Officer from 2007 to 2014.
Dr. Greenwald's current jobs include serving as a Board of Directors member at Jaguar Gene Therapy LLC since 2020, Innervace, Inc. since 2022, and as Vice President at Deerfield Management Co. LP (Private Equity) since 2018.
Dr. Greenwald's former jobs include serving as Director at Decision Resources, Inc. from 2014 to 2015 and as Director at Johns Hopkins Technology Ventures from 2014 to 2018.
Dr. Greenwald received his undergraduate degree from the University of Maryland in 2004 and his doctorate degree from Tufts University School of Medicine in 2010.
Postes actifs de David Greenwald
| Sociétés | Poste | Début |
|---|---|---|
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Private Equity Investor | 01/09/2018 |
Innervace, Inc.
 Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim. | Directeur/Membre du Conseil | 01/08/2022 |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Directeur/Membre du Conseil | 01/02/2020 |
Anciens postes connus de David Greenwald
| Sociétés | Poste | Fin |
|---|---|---|
| Johns Hopkins Technology Ventures | Directeur/Membre du Conseil | 01/09/2018 |
Decision Resources, Inc.
 Decision Resources, Inc. Investment ManagersFinance Decision Resources, Inc. provides information, analysis, and insight on critical issues to the healthcare industry worldwide. It provides market research publications, advisory and consulting services for pharmaceutical companies, managed care organizations, and medical device manufacturers. The company was founded in 1990 and is headquartered in Burlington, MA. | Directeur/Membre du Conseil | 01/07/2015 |
Relay Technology Management, Inc.
 Relay Technology Management, Inc. Miscellaneous Commercial ServicesCommercial Services Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development. Data-driven decision-making in turn will lead to cures for patients around the world becoming available faster. The Relay Innovation Engine software platform powers the Business Development Live software-as-a-service and their strategy consulting practice, which supports business development and corporate strategy professionals by aggregating scientific, business and medical data in an actionable context. Relay works with life science companies to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics. Relay was founded by David Greenwald, Ph.D. and Brigham Hyde, Ph.D. | Directeur Général | 01/01/2014 |
Formation de David Greenwald
| University of Maryland | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Decision Resources, Inc.
Decision Resources, Inc. Investment ManagersFinance Decision Resources, Inc. provides information, analysis, and insight on critical issues to the healthcare industry worldwide. It provides market research publications, advisory and consulting services for pharmaceutical companies, managed care organizations, and medical device manufacturers. The company was founded in 1990 and is headquartered in Burlington, MA. | Finance |
Relay Technology Management, Inc.
Relay Technology Management, Inc. Miscellaneous Commercial ServicesCommercial Services Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development. Data-driven decision-making in turn will lead to cures for patients around the world becoming available faster. The Relay Innovation Engine software platform powers the Business Development Live software-as-a-service and their strategy consulting practice, which supports business development and corporate strategy professionals by aggregating scientific, business and medical data in an actionable context. Relay works with life science companies to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics. Relay was founded by David Greenwald, Ph.D. and Brigham Hyde, Ph.D. | Commercial Services |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Finance |
| Johns Hopkins Technology Ventures | |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Health Services |
Innervace, Inc.
Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim. | Health Technology |